What one share of Lipocine holds
Lipocine’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.23 |
|---|---|
| Profit | −$1.75 |
| Cash and investments | $0.60 |
| Book value | $2.64 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2012 | $29.41 | $14.50 | $0.05 | −$12.17 | — | $20.28 |
| 2013 | $0.00 | −$24.45 | $0.00 | −$19.83 | — | $60.15 |
| 2014 | — | −$27.13 | $0.08 | −$23.12 | — | $35.02 |
| 2015 | — | −$18.79 | $0.03 | −$15.88 | — | $39.12 |
| 2016 | $0.00 | −$17.66 | $0.06 | −$17.08 | — | $23.96 |
| 2017 | $0.00 | −$17.79 | $0.00 | −$14.16 | — | $15.17 |
| 2018 | $0.34 | −$9.28 | $0.00 | −$9.62 | — | $7.38 |
| 2019 | $0.11 | −$8.54 | — | — | — | $2.84 |
| 2020 | $0.00 | −$6.40 | — | — | — | $3.72 |
| 2021 | $3.13 | −$0.17 | $0.00 | −$0.86 | — | $8.77 |
| 2022 | $0.10 | −$2.15 | $0.03 | −$2.30 | — | $6.81 |
| 2023 | — | −$3.14 | $0.00 | −$2.25 | — | $3.83 |
| 2024 | $2.07 | −$0.00 | $0.02 | −$0.24 | — | $3.93 |
| 2025 | $0.35 | −$1.69 | — | — | — | $2.35 |
Common questions about Lipocine
How much does one share of Lipocine earn?
Over the last 12 months, Lipocine lost $1.75 for each share on $0.23 of sales.
Does Lipocine pay a dividend?
Lipocine didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Lipocine’s book value per share?
Lipocine’s book value is $2.64 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Lipocine have?
Each share of Lipocine has $0.60 of cash and investments, as of June 30, 2026.
Has Lipocine bought back shares?
Lipocine’s share count rose about 2078% from 2012 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.